Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Pharm Ther ; 42(4): 502-505, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28488314

ABSTRACT

WHAT IS KNOWN AND OBJECTIVE: Neuroleptic malignant syndrome (NMS) is a rare but severe adverse effect of antipsychotic drugs. CASE DESCRIPTION: We report two cases of NMS highlighted by clinical pharmacists in an emergency unit during summer. One of them was fatal. Medication reconciliation processes performed at admission identified treatment with loxapine for one of them and with loxapine and clozapine for the other. Interview of the patients highlighted clinical symptoms suggesting NMS, allowing the pharmacists to alert the medical team. WHAT IS NEW AND CONCLUSION: Adverse drug events may be severe and clinical pharmacists in emergency departments can help to detect them.


Subject(s)
Antipsychotic Agents/adverse effects , Neuroleptic Malignant Syndrome/diagnosis , Pharmacists/organization & administration , Aged , Antipsychotic Agents/administration & dosage , Clozapine/administration & dosage , Clozapine/adverse effects , Emergency Service, Hospital/organization & administration , Fatal Outcome , Humans , Loxapine/administration & dosage , Loxapine/adverse effects , Male , Middle Aged , Neuroleptic Malignant Syndrome/etiology , Pharmacy Service, Hospital/organization & administration , Professional Role
SELECTION OF CITATIONS
SEARCH DETAIL
...